Atlas Trials

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

Clinical trial NCT04550832 · COMPLETED

Trial details

NCT number
NCT04550832
Sponsor
LigaChem Biosciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Infections and InfestationsPulmonary Tuberculosis
Start date
2021-10-28
Primary completion
2023-01-04
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.